Does Rallies show 13F holders for VTRS?

Yes. Rallies tracks hedge fund and 13F ownership data for VTRS, including fund names, share counts, latest tracked quarter, and position changes when available.

Is VTRS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VTRS. It does not provide personalized investment advice.

VTRS (Viatris Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Viatris Inc. Common Stock (VTRS) is a publicly traded Healthcare sector company. As of May 20, 2026, VTRS trades at $16.55 with a market cap of $19.22B and a P/E ratio of -63.67. VTRS moved +2.75% today. Year to date, VTRS is +34.11%; over the trailing twelve months it is +86.82%. Its 52-week range spans $6.85 to $17.53. Analyst consensus is buy with an average price target of $17.14. Rallies surfaces VTRS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns VTRS stock?

Hedge funds tracked by Rallies that own VTRS include Glenview Capital, DME Capital, Bridgewater Associates, Pinebridge Investments, and Berkshire Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Viatris Inc. Common Stock.

VTRS Key Metrics

Key financial metrics for VTRS
Metric	Value
Price	$16.55
Market Cap	$19.22B
P/E Ratio	-63.67
EPS	$-0.26
Dividend Yield	0.12%
52-Week High	$17.53
52-Week Low	$6.85
Volume	8.56M
Avg Volume	0
Revenue (TTM)	$14.56B
Net Income	$-296.50M
Gross Margin	34.40%

Top Hedge Funds Holding VTRS

Glenview Capital holds 9.09M shares of VTRS, changed -18.04% as of Mar 31, 2026.
DME Capital holds 1.82M shares of VTRS, changed -69.71% as of Mar 31, 2026.
Bridgewater Associates holds 725.88K shares of VTRS, changed -49.05% as of Mar 31, 2026.
Pinebridge Investments holds 241.20K shares of VTRS, changed -7.95% as of Sep 30, 2024.
Berkshire Asset holds 21.87K shares of VTRS, changed -2.65% as of Mar 31, 2026.

Latest VTRS News

Viatris jumps after Q1 2026 beat and reaffirmed full-year guidance — May 7, 2026
Viatris Q1 Revenues Up 8% to $3.52B, Adjusted EBITDA Up 14% to $1.05B — May 7, 2026
Viatris jumps ahead of May 7 earnings, dividend reaffirmation, and CFO transition — May 6, 2026
Viatris CFO Mistras to Depart May 22; Paul Campbell Becomes Interim CFO — May 4, 2026
Viatris jumps 3% as investors lean into 2030 growth plan and raised targets — Apr 20, 2026

Recent VTRS Insider Trades

Campbell Paul sold 21.35K (~$283.54K) on Mar 23, 2026.
SIMMONS DAVID S bought 213 (~$2.22K) on Nov 3, 2025.
Le Goff Corinne sold 7.03K (~$72.04K) on Sep 11, 2025.

VTRS Analyst Consensus

7 analysts cover VTRS: 0 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.14.

Common questions about VTRS

Who owns VTRS stock?: Hedge funds tracked by Rallies that own VTRS include Glenview Capital, DME Capital, Bridgewater Associates, Pinebridge Investments, and Berkshire Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Viatris Inc. Common Stock.
Does Rallies show 13F holders for VTRS?: Yes. Rallies tracks hedge fund and 13F ownership data for VTRS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is VTRS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VTRS. It does not provide personalized investment advice.